Trial intelligence / Profile preview

Comparison of Pudendal Nerve Block With Ropivacaine and Intravenous Tramadol for Prevention of CRBD

NCT02683070Unknown

Sponsor
West China Hospital of Sichuan University
Start
Mar 2016
Primary completion
Feb 2018
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

Randomised, single-blind trial of ropivacaine hydrochloride liposomal suspension injection in cystitis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of postoperative catheter-related bladder discomfort at 1 day. Status: unknown.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

cystitis

Beyond the preview

Go deeper on NCT02683070.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02683070.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call